Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

NCT07499674 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Lung Metastases

Interventions

DRUG: Abenacianine
OTHER: Near Infrared (NIR) Imaging

Sponsor

Vergent Bioscience, Inc.